14B Captial Management LP
Annual return '25
+54.7%
SPY '25
+17.7%
Alpha
+37.0ptsvs SPY
Invested
$1.2B
Holdings
16
Trades YTD
0
Performance · Fund vs SPY
Cumulative return · quarterly snapshotsCoverage 100%. 4 quarters of 2025 measured against SPY adj-close benchmark.
Top holdings · current snapshot
Source: 13F-HR01
$PTGX
Protagonist Therapeutics Inc.
Held since at least Q1 2024
38.7%
02
$NBTX
Nanobiotix S.A.
Held since at least Q1 2024
23.5%
03
$RAPP
Rapport Therapeutics, Inc.
Held since at least Q1 2024
9.8%
04
$MGTX
MeiraGTx Holdings plc
Held since at least Q1 2024
9.6%
05
$CVRX
CVRx, Inc.
Held since at least Q1 2024
5.2%
06
$CTNM
Contineum Therapeutics Inc.
Held since at least Q1 2024
4.1%
07
$LEGN
Legend Biotech Corporation
Held since at least Q1 2024
3.2%
08
$XNCR
Xencor, Inc.
Held since at least Q1 2024
2.1%
09
$PRCT
Procept BioRobotics Corporation
Held since at least Q1 2024
2.0%
10
$FATE
Fate Therapeutics, Inc.
Held since at least Q1 2024
0.6%
Recent trades · Last 90 days
No Form 4 / 13D / 13G trade events on file in the recent window. 13F filers report position snapshots quarterly rather than per-trade events, so this section is most useful for managers who also file Form 4 or 13D/G.
Convergence · Pattern Engine ships in v1.1
30-day windowIn development
Convergence participation lands with the Pattern Engine.
Once the Pattern Engine ships, this section will list every active convergence event this fund is named in — with the other named funds, the Congress members on the same name, and combined position size.
Source data: SEC EDGAR · 13F-HR filings · Performance through 2025-12-31 · Last refreshed 08:24 UTC.